Clinical Trials Logo
  1. Home
  2. Iron Deficiency
  3. NCT03924271
  4. Details
NCT03924271 Clinical Trial

Prevalence Study of Iron Deficiency in Patients With Cancer

Iron-deficiency Clinical Trial

— CARENFER ONCO  

Official title:
Prevalence Study of Iron Deficiency in Patients With Cancer

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT03924271
Other study ID # CARENFER ONCO HEMATO
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 15, 2019
Est. completion date June 30, 2019

Study information
Verified date April 2019
Source VIFORFRANCE
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Despite its high prevalence, a recent study conducted by Prof. Cacoub (unpublished) on the french national health insurance database showed that iron deficiency was an underdiagnosed and under-treated co-morbidity. In inflammatory situations, especially during cancer, the measurement of the transferrin saturation factor is only performed in about 10% of cases whereas this measure is recommended in inflammatory situations including cancer (French Health High Authority 2011)

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 1200
Est. completion date June 30, 2019
Est. primary completion date June 30, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient, male or female, over the age of 18

- Patient in an oncology department (any type of tumor, any type of treatment, initiated or not)

- Patient affiliated or beneficiary of a social security system

- Patient with written consent

Exclusion Criteria:

- Protected patient: major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision

- Patient hospitalized without consent

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• Iron deficiency testing
Blood sample for complete iron status

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
VIFORFRANCE

Outcome
Type Measure Description Time frame Safety issue
Primary Blood iron status ferritin, haemoglobin, transferrin saturation factor One day
See also
  Status Clinical Trial Phase
Completed NCT04949165 - Bloodsafe Ghana- Iron and Nutritional Counseling Strategy Pilot Study N/A
Terminated NCT03218384 - Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency Phase 2
Active, not recruiting NCT03516734 - Iron-fortified Lentils to Improve Iron (Fe) Status in Bangladesh N/A
Completed NCT03572010 - Stable Iron Isotope Method in HIV+ and HIV- Children N/A
Active, not recruiting NCT03703726 - Iron Absorption From Fortified Extruded Rice Using Different Extruding Temperatures. N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Not yet recruiting NCT05395468 - Diagnosis of Iron Deficiency by Artificial Intelligence Analysis of Eye Photography.
Withdrawn NCT03800446 - Validation of a Point-of-care Device Measuring Ferritin With Capillary Blood N/A
Not yet recruiting NCT03353662 - Sub Regional Micronutrient Survey in Ethiopia
Completed NCT03819530 - Child of Urban Poverty Iron Project (CUPIP) - A Pilot Study N/A
Recruiting NCT04144790 - Impact of Iron Supplementation Treatment on Brain Iron Concentrations
Completed NCT03957057 - Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia Phase 3
Completed NCT03642223 - Central and Peripheral Adiposity and Iron Absorption N/A
Not yet recruiting NCT05407987 - Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) Phase 3
Withdrawn NCT03873584 - Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
Enrolling by invitation NCT03897673 - Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas N/A
Completed NCT04359368 - Characteristics of Patients With Hypersensitivity Reactions to Intravenous Iron Infusions
Active, not recruiting NCT04778072 - A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects N/A
Enrolling by invitation NCT05750940 - Oxidative Skeletal Muscle Metabolism in Chronic Heart Failure Patients With and Without Iron Deficiency
Recruiting NCT05126901 - Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years Phase 3